MSF responds to WHO’s Global TB Report 2025: Governments and donors must close the deadly gap in diagnosing and treating TB in children

The laboratory team at the National Tuberculosis Institute conducts TB testing using modern tools and techniques. ©️Deniz Fahmi/MSF

Geneva, 12 Nov 2025 – The World Health Organization’s (WHO) Global Tuberculosis Report 2025 released today shows that 1.2 million children and young adolescents (aged less than 15 years) fell ill with tuberculosis (TB) in 2024. Children continue to be disproportionately affected by TB, with an estimated 174,300 deaths amongst children in 2024, accounting for 14.2% of all TB deaths. A staggering 43% of the children with TB missed diagnosis and could not access treatment, showing no improvement from the previous year.

The data released by WHO today once again underlines how tuberculosis continues to heavily impact children, with one child dying of the disease every 3 minutes in 2024. With the shocking cuts in international aid we are seeing this year, the children will be hit hardest as they already face the largest gaps in accessing TB care. We urge governments to prioritise the implementation of WHO-recommended tools and strategies to prevent, diagnose, and treat tuberculosis in children, and we urge international donors and technical agencies to step up funding and support for these efforts. MSF also calls on industry and international funders of research & development to ensure sufficient and sustained investments in the development of better tests and medicines for children. It’s time to turn the tide on tuberculosis, stop the suffering, and save more children’s lives.
Dr Cathy Hewison
Tuberculosis Platform Leader, Médecins Sans Frontières

MSF has been providing tuberculosis (TB) care for 30 years, working alongside national health authorities to treat people in a wide variety of settings, including conflict zones, impoverished urban communities, prisons, refugee camps, and rural areas. In 2024, MSF treated 25,000 people with TB, including 1500 patients with drug-resistant TB, in over 35 countries, with most patients being in Africa (68 per cent) and Asia (30 per cent).

In 2023, MSF launched the Test Avoid Cure TB in Children (TACTiC) project with an aim to implement the latest WHO recommendations for the management of TB in children, as well as generating evidence on the accuracy, feasibility, and acceptability of the WHO treatment decision algorithms and advocating for their implementation at global and national levels. The TACTiC project covers 12 countries with a high burden of TB where MSF provides TB care for children: Afghanistan, Central African Republic, Democratic Republic of Congo, Guinea, Mozambique, Niger, Nigeria, Pakistan, the Philippines, Somalia, South Sudan, and Uganda.





Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons